Neuroglia at the crossroads of homoeostasis, metabolism and signalling: evolution of the concept by Parpura, Vladimir & Verkhratsky, Alexei
Neuroglia at the crossroads of
homoeostasis, metabolism and
signalling: evolution of the concept
Vladimir Parpura*
,{,{,11 and Alexei Verkhratsky
{,{,I1
*Department of Neurobiology, Center for Glial Biology in Medicine, Atomic Force Microscopy and Nanotechnology Laboratories,
Civitan International Research Center, Evelyn F. McKnight Brain Institute, University of Alabama, Birmingham, AL 35294, U.S.A.
{IKERBASQUE, Basque Foundation for Science, 48011, Bilbao, Spain
{Department of Neurosciences, University of the Basque Country UPV/EHU, 48940, Leioa, Spain
1School of Medicine, University of Split, 21000 Split, Croatia
IFaculty of Life Sciences, The University of Manchester, Manchester, M13 9PT, U.K.
Cite this article as: Parpura V and Verkhratsky A (2012) Neuroglia at the crossroads of homoeostasis, metabolism and signalling: evolution of the
concept. ASN NEURO 4(4):art:e00087.doi:10.1042/AN20120019
ABSTRACT
Ever since Rudolf Virchow in 1858 publicly announced his
apprehension of neuroglia being a true connective
substance, this concept has been evolving to encompass
a heterogeneous population of cells with various forms and
functions. We briefly compare the 19th–20th century
perspectives on neuroglia with the up-to-date view of
these cells as an integral, and possibly integrating,
component of brain metabolism and signalling in heath
and disease. We conclude that the unifying property of
otherwise diverse functions of various neuroglial cell sub-
types is to maintain brain homoeostasis at different levels,
from whole organ to molecular.
Key words: Alzheimer’s disease, astrocyte, disease, health,
neuron, white matter.
INTRODUCTION
‘Ich habe bis jetzt, meine Herren, bei der Betrachtung des
Nervenapparatus immer nur der eigentlich nervo ¨sen Theile
gedacht. Wenn man aber das Nervensystem in seinem
wirklichen Verhalten im Ko ¨rper studiren will, so ist es
ausserordentlich wichtig, auch diejenige Masse zu kennen,
welche zwischen den eigentlichen Nerventheilen vorhanden
ist, welche sie zusammenha ¨und dem Ganzen mehr oder
weniger seine Form gibt.’
(‘Hitherto, gentlemen, in considering the nervous system, I
have only spoken of the really nervous parts of it. But if we
would study the nervous system in its real relations in the
body, it is extremely important to have a knowledge of that
substance also which lies between the proper nervous parts,
holds them together and gives the whole its form in a greater
or less degree’; translated from German) – Rudolf Virchow,
Die Cellularpathologie, p. 246 (Virchow, 1858).
With these words, Rudolf Virchow publicly announced the
concept of neuroglia when delivering a lecture to medical
students of Charite Hospital in Berlin on 3 April 1858. The
actual term neuroglia appeared 2 years earlier in Virchow’s
commentary to his own paper; here Virchow contemplated
the existence of ‘…connective substance, which forms in the
brain, in the spinal cord, and in the higher sensory nerves a
sort of Nervenkitt (neuroglia), in which the nervous system
elements are embedded’ (Virchow, 1856).
For Virchow, the neuroglia was a true connective tissue
(the Zwichenmasse – ‘in between tissue’ of mesodermal
origin), which most likely did not have a cellular origin, but
was represented by fibres and intercellular masses. Although
the first histological images of neuroglial cells were drawn by
Heinrich Mu ¨ller, Max Schulze (retinal Mu ¨ller cells; Mu ¨ller,
1851), Karl Bergmann (cerebellar Bergmann glia; Bergmann,
1857) and Otto Deiters [stellate astrocytes (Deiters, 1865); see
also Kettenmann and Verkhratsky (2008) for an historic
account], the first in-depth investigation of neuroglia was
performed by Camillo Golgi in early 1870s (Golgi, 1873,
1903). It was also Golgi who, after discovering glial-vascular
contacts or end feet (Figure 1A), introduced the first grand
theory of glial function; this theory postulated that, in the
CNS (central nervous system), glial cells provide for the bridge
between vasculature and the organ parenchyma and are
therefore responsible for metabolic support and substance
exchange. These CNS glial cells were soon named ‘astrocytes’
by Michael von Lenhosse ´k (Lenhosse ´k, 1891); they were
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asnneuro.org / Volume 4 (4) / art:e00087 201further classified into protoplasmic (grey matter) and fibrous
(white matter) astrocytes (Andriezen, 1893).
Research into neuroglia was very much advanced by
Santiago Ramo ´n y Cajal and his pupils. Cajal developed a gold
chloride-sublimate staining technique (Ramo ´n y Cajal, 1913)
that was specific for both protoplasmic and fibrous astrocytes
[as we know now this technique labels the intermediate
filament GFAP (glial fibrillary acidic protein), which is widely
used today as an astrocytic marker]. Cajal found very close
appositions between astroglia and neurons (Figure 1B) and
thought that astrocytes could work as insulators ascertaining
spatial specificity of information flow in the neural circuits.
B yt h et u r no ft h e2 0 t hc e n t u r yt h en o t i o no ft h e
extraordinary morphological heterogeneity of the CNS glia
was also firmly established (Figure 1C).
Cajal’s pupil Pı ´o del Rı ´o-Hortega identified two other
principal classes of glial cells, initially considered by Cajal as
the ‘third element’ (a group of adendritic cells) and what
represented the oligodendrocytes and the microglia (Del Rı ´o-
Hortega, 1921, 1932). Incidentally, oligodendrocytes were
first observed (with a specific platinum stain technique) and
described by William Ford Robertson (Robertson, 1899) who,
however, did not understood the role of these cells and
identified them as mesoglia.
The idea of active neuronal–glial interactions as a
substrate for brain function was first introduced in 1894
by Carl Ludwig Schleich (Schleich, 1894) (Figure 1D).
According to Schleich, glial cells represented the general
inhibitory mechanism in the brain; swelling/shrinking of
glial perisynaptic processes controlled information flow
through synapses. Maximal swelling of the glial cells fully
inhibited synaptic transmission and plunged the brain into a
coma, which, for example, underlies general anaesthesia.
Similar ideas were developed by Cajal, who suggested that
swelling of perineuronal glia may terminate transmission
a n de v e nc o n s i d e r e dt h i st ob eam e c h a n i s mo fs l e e p
(Ramo ´n y Cajal, 1925). Another of Cajal’s pupils, Fernando
De Castro, suggested that neuroglial cells may release
neuroactive substances and directly participate in neural
transmission (De Castro, 1951).
Figure 1 Early 20th century survey of glial biology in medicine: form and function
(A) Camillo Golgi’s drawings of astrocytes contacting blood vessels (from Golgi, 1903). (B) The close envelopment of neurons by the
processes of neuroglial cells as seen by Santiago Ramo ´n y Cajal (redrawn from Cajal’s original plate by De Castro, from Glees, 1955).
(C) Morphological diversity of neuroglia in human fetal cortex (Retzius, 1894–1916, Vol. 6, Plate II, Figure 5). (D) Close interactions
between neuroglial (red) and neuronal (black) networks (from Schleich, 1894). (E) Oligodendroglia of the white matter and one
astrocyte with a vascular endfoot showing the distribution of darkly stained granules or gliosomes in their processes (from Penfield,
1924), the image is taken from Glees (1955). (F) Pathological potential of neuroglia. The drawing by Alois Alzheimer (Alzheimer,
1910) shows association of glial cells (glz) with pathologically modified neurons (gaz or ganglion cells).
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1909) and Jean Nageottte (Nageotte, 1910; see also Glees,
1955 for review). Using his molybdenum haematoxylin stain,
Held discovered darkly stained granular inclusions (granules) in
processes of specialized astrocytes, marginal (subpial) glial
cells. This stain also allowed him to determine that glial fibres
were actually cellular extensions (but not interstitial mass as
per Virchow) forming an elaborate three-dimensional inter-
cellular (astrocytic) network that interacts with vascular
endothelium. These two findings led him to hypothesize that
granular inclusions he observed, and referred to as ‘gliosomes’
by Alzheimer (Alzheimer, 1910), represent evidence for glial
secretion or metabolic proviso for neurons, since glial cells
reside at the interface between the blood vessels and brain
parenchyma. As Penfield (Penfield, 1924) improved his staining
methods to better disclose oligodendrocytic processes, it
became apparent that gliosomes can be seen in astrocytes
and oligodendrocytes alike (Figure 1E). It was Nageotte,
however, who provided the first description of secretion in
neuroglia using the Altmann aniline-acid fuchsin staining
method (see the English translation of this report in
Verkhratsky et al., 2011). He observed various secretory grains,
which he thought represented successive transformation steps
from mitochondria into grains. Gliosomes in the cytoplasm of
glial cells were, under various terms, also reported by other
microanatomists of that era: Eisath (1906), Fieandt (1910),
Cajal (1913), Achucarro (1913) and Hortega (1916) (Glees,
1955, and references therein). It should be noted that the early
20th century term gliosomes should neither be confused with
nor matched to its recent usage (Stigliani et al., 2006) for glial
subcellular re-sealed particles (Nakamura et al., 1993), which
are secretion competent pinched off astrocytic processes
containing transmitter-laden vesicles (Stigliani et al., 2006).
Besides secretory capabilities, in the first decade of the 20th
century, glial function to metabolize and take up transmitters
was speculated by Ernesto Lugaro (Lugaro, 1907).
Finally, neuroglial cells were implicated in various patho-
logical processes. Nissl and Alzheimer considered the
pathological role of neuroglia (Figure 1F) in a variety of
neurological diseases (Alzheimer, 1910), and astrocytes were
considered to ‘exhibit a morbid hypertrophy in pathological
conditions’ by Andriezen (Andriezen, 1893). The role of
astrocytes in scar formation was perceived by Cajal, Hortega
and Penfield in the early 1920s (see Glees, 1955).
The above-outlined hypotheses with regard to glial
function were unexplored for about three-quarters of the
century as glial research was pushed aside due to a
combination of (i) the victory of the neuronal doctrine
which considers neurons as the sole determinant of brain
signalling and (ii) the technical inability to study the function
of glial cells since they lack traditional electrical excitability
in the form of action potentials. Following this neglect,
however, it took about three decades to provide data in
support of neuroglia as an integral (and possibly integrating)
component of the brain action. As a consequence we have
guest edited a special online collection for ASN NEURO
entitled ‘Neuroglia–more thana nervenkitt’,which encompasses
acollectionofreviewarticlesalongwithoriginalresearchpapers
(http://www.asnneuro.org/an/online_collection.htm). By no
means can we claim that this collection represents an all-
inclusivecoverage of the rapidly expanding fields of glial biology
andbidirectional glial–neuronal interactions. Rather, the goal of
this collection is to integrate the body of information that has
accumulated during these recent years in a selected subset of
topics to illustrate the active role of glia in (patho)physiological
processes in the CNS.
Astrocytes display excitability based on variations of their
cytosolic Ca
2+ levels (Cornell Bell et al., 1990). A prominent
output of this process is evident in the Ca
2+-dependent
exocytotic/vesicular release of chemical transmitters, most
notably ATP and glutamate, from astrocytes, which is the
subject reviewed by Zorec et al. (2012). This essay des-
cribes Ca
2+ sources and sinks that provide for astrocytic
intracellular Ca
2+ dynamics, which are necessary and sufficient
for regulation of the exocytotic release of transmitters. It also
discusses the secretory machinery, which supports this release
mechanism, together with the description of secretory vesicles
in astrocytes. It is the traffic of these transmitter-storing
vesicles that in due course results in setting transmitter(s) free
into the extracellular space. Transmitter(s) released from
astrocytes affect neuronal excitability and the sleep homoeo-
stat behaviour. Besides such physiological signalling, this route
can also play a role in pathophysiology, and as such there is a
concise discussion on its contribution to epilepsy. This review
article is accompanied by the original research paper by Reyes
et al. (2012), which reports on the role of the plasmalemmal
NCX (Na
+/Ca
2+ exchanger) in exocytotic glutamate release
from astrocytes. It is proposed that this exchanger, by
operating in reverse mode, i.e. delivering Ca
2+ from the
extracellular space into the cytosol, could be involved in fast
and spatially restricted exocytosis in astrocytes. Such a
pathway would operate in parallel to a more accepted and
widely distributed, albeit slower, exocytotic pathway in
astrocytes, which predominately depends on Ca
2+ drawn from
the ER (endoplasmic reticulum) store upon, for example,
activation of metabotropic receptors. Since NCX-associated
Ca
2+ dynamics are inherently coupled to astrocytic cytosolic
Na
+ control, this could also have significance to astrocytic
metabolism. Namely, astrocytic cytosolic Na
+ increases can
lead to lactate production, which upon release from astrocytes
can be taken up and utilized by nearby neurons, a process
referred to as lactate shuttle (Pellerin and Magistretti, 2011).
The issue of lactate against glucose utilization for energy
consumption of needy neurons and the brain in general has
been a matter of an ongoing debate (Dienel, 2011).
At this juncture, we transition to the neuroenergetics area.
Kreft et al. (2012) provide a review of astrocytic glucose
metabolism at the interface of intra- and inter-cellular
signalling. The emphasis has been placed on the effects that
the two major signalling molecules, ATP and glutamate (along
with this amino acid homoeostasis), as well as adrenergic
receptor activation have on astrocytic metabolism with an
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203outlook on the contribution of the third, astrocytic, partner
in the tripartite synapse. A contentious notion that metabolic
events can be compartmentalized at the level of a single
astrocyte is then discussed. Similarly the original research
article by Bak et al. (2012) follows up on the compartmenta-
lization theme of glucose and lactate metabolism in neuronal
parts contributing to the tripartite synapse. It appears that
pre- and post-synaptic compartments metabolize glucose,
while the postsynaptic compartment utilizes both glucose and
lactate. However, the postsynaptic usage of glucose, unlike
that of lactate, positively correlates with Ca
2+ signalling in
glutamatergic neurons. This raises the notion that Ca
2+
signalling may represent a router for utilization of glucose
against lactate as a preferred metabolic substrate at the
postsynaptic terminals.
Neuroglial cells in their capacity as homoeostatic cells (see
below) of the CNS are involved essentially in all types of
neurological and psychiatric disorders. Astrocytes respond to
the nervous system insult by a complex defensive reaction
known as reactive astrogliosis, which manifests as cellular
hypertrophy and GFAP overexpression. Interestingly, the mu-
tations of the gene encoding for GFAP result in the human
disorder named Alexander disease. Verkhratsky et al.
(2012) review this topic to provide up-to-date information
of the astrocytic contribution to Alexander disease and AD
(Alzheimer disease), ischaemia, stroke and epilepsy. The
review calls for development of comprehensive therapeutic
approaches, which in addition to presently used agents, all
acting upon neurons, would also utilize agents targeting glia
to ameliorate brain disorders. The original research paper in
this area provided by Yeh et al. (2011) deals with astro-
cytic morphofunctional changes in AD; there is an astrocytic
atrophy (in contrast with hypertrophy as per Andriezen) in
the entorhinal cortex of a transgenic animal model of this
neurodegenerative disease. Thus astrocytic atrophy could be
considered as a target for future therapeutic intervention in
AD. Finally, Matute and Ransom (2012) review the inter-
cellular signalling molecules, ATP and glutamate, that
underlie signalling in heath and disease within the white
matter, greatly composed of neuroglia and axons; stroke,
multiple sclerosis and AD are discussed.
Our understanding of the role and place of neuroglia in the
brain remains scattered and superficial. Even the definition of
neuroglia is not agreed upon by the field, as generally neu-
roglial cells are defined as all cells in the brain which are not
neurons. This loose and by exclusion definition hampers the
fact of profound heterogeneity of glial cell forms and
functions. Indeed neuroglia embraces a host of cells with very
different origin, morphology and function. The primary
neuroglial cells in the CNS are of ectoderm in origin and
represented by astrocytes, oligodendrocytes and NG-2-positive
cells; the astrocytes in addition include several types of radial
glia, numerous specialized astrocytes (e.g. velate, interlaminar
or polarized astrocytes), choroid plexus cells and ependymo-
cytes. The microglia is altogether different, being of mesoderm
in origin, a myeloid descent, and an invading alien to the brain.
There is, however, one unifying property of all these cells –
their primary function is to maintain brain homoeostasis at
different levels, from whole organ (control of blood–brain
barrier and defence) to cellular (neurogenesis, synaptogenesis
and synapse maintenance) and molecular (ion and neuro-
transmitter homoeostasis). Therefore neuroglia can be broadly
defined as homoeostatic cells of the nervous system.
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